Harrow Health, Inc. (HROW)
NASDAQ: HROW · IEX Real-Time Price · USD
10.53
+0.53 (5.30%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Harrow Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 130.19 | 88.6 | 72.48 | 48.87 | 51.17 | 41.37 | 26.77 | 19.94 | 9.72 | 1.66 | Upgrade
|
Revenue Growth (YoY) | 46.95% | 22.24% | 48.30% | -4.48% | 23.67% | 54.52% | 34.26% | 105.25% | 485.30% | 16500.00% | Upgrade
|
Cost of Revenue | 39.64 | 25.38 | 18.21 | 14.46 | 16.75 | 16.52 | 13.51 | 9.83 | 5.21 | 1.09 | Upgrade
|
Gross Profit | 90.55 | 63.21 | 54.26 | 34.41 | 34.42 | 24.85 | 13.27 | 10.11 | 4.51 | 0.57 | Upgrade
|
Selling, General & Admin | 83.09 | 58.24 | 41.32 | 31.25 | 33.09 | 29.24 | 25.02 | 24.95 | 19 | 10.48 | Upgrade
|
Research & Development | 6.65 | 3.05 | 11.08 | 2.41 | 2.08 | 0.83 | 0.41 | 0.74 | 0.33 | 0.24 | Upgrade
|
Other Operating Expenses | 0.38 | 0 | 0.25 | 0.36 | 4.04 | 0 | 0 | 0.3 | 0 | 0 | Upgrade
|
Operating Expenses | 90.12 | 61.29 | 52.65 | 34.02 | 39.21 | 30.07 | 25.43 | 25.99 | 19.33 | 10.71 | Upgrade
|
Operating Income | 0.43 | 1.92 | 1.61 | 0.39 | -4.8 | -5.22 | -12.16 | -15.88 | -14.82 | -10.15 | Upgrade
|
Interest Expense / Income | 21.32 | 7.24 | 5.44 | 2.24 | 2.5 | 2.73 | 3.03 | 2.77 | 1.11 | -0.03 | Upgrade
|
Other Expense / Income | 2.82 | 8.69 | 14.05 | 1.5 | -7.47 | -22.57 | -2.27 | 0.54 | -0.03 | - | Upgrade
|
Pretax Income | -23.71 | -14.01 | -17.87 | -3.35 | 0.18 | 14.63 | -12.92 | -19.2 | -15.9 | -10.12 | Upgrade
|
Income Tax | 0.7 | 0.08 | 0.13 | 0 | 0.01 | 0 | -0.94 | -0.11 | 0 | 0 | Upgrade
|
Net Income | -24.41 | -14.09 | -18.01 | -3.36 | 0.17 | 14.63 | -11.99 | -19.09 | -15.9 | -10.12 | Upgrade
|
Preferred Dividends | 0 | 0 | 0.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Net Income Common | -24.41 | -14.09 | -18.48 | -3.36 | 0.17 | 14.63 | -11.99 | -19.09 | -15.9 | -10.12 | Upgrade
|
Net Income Growth | - | - | - | - | -98.85% | - | - | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 33 | 27 | 27 | 26 | 25 | 22 | 20 | 13 | 10 | 9 | Upgrade
|
Shares Outstanding (Diluted) | 33 | 27 | 27 | 26 | 26 | 24 | 20 | 13 | 10 | 9 | Upgrade
|
Shares Change | 18.78% | 2.63% | 3.33% | -2.16% | 11.15% | 18.90% | 57.16% | 33.07% | 4.85% | 5.50% | Upgrade
|
EPS (Basic) | -0.75 | -0.51 | -0.69 | -0.13 | 0.01 | 0.67 | -0.60 | -1.50 | -1.66 | -1.11 | Upgrade
|
EPS (Diluted) | -0.75 | -0.51 | -0.69 | -0.13 | 0.01 | 0.61 | -0.60 | -1.50 | -1.66 | -1.11 | Upgrade
|
EPS Growth | - | - | - | - | -98.36% | - | - | - | - | - | Upgrade
|
Free Cash Flow | 2.38 | -0.86 | 3.3 | -1.96 | -0.52 | -1.08 | -9.58 | -18.1 | -12.14 | -7.23 | Upgrade
|
Free Cash Flow Per Share | 0.07 | -0.03 | 0.12 | -0.08 | -0.02 | -0.05 | -0.48 | -1.42 | -1.27 | -0.79 | Upgrade
|
Gross Margin | 69.55% | 71.35% | 74.87% | 70.41% | 67.26% | 60.07% | 49.56% | 50.70% | 46.42% | 34.16% | Upgrade
|
Operating Margin | 0.33% | 2.17% | 2.23% | 0.79% | -9.37% | -12.61% | -45.43% | -79.64% | -152.55% | -611.27% | Upgrade
|
Profit Margin | -18.75% | -15.90% | -25.50% | -6.87% | 0.33% | 35.35% | -44.76% | -95.71% | -163.64% | -609.52% | Upgrade
|
Free Cash Flow Margin | 1.83% | -0.97% | 4.55% | -4.01% | -1.01% | -2.61% | -35.76% | -90.77% | -124.93% | -435.60% | Upgrade
|
Effective Tax Rate | - | - | - | - | 4.55% | - | - | - | - | - | Upgrade
|
EBITDA | 9.95 | -3.1 | -10.04 | 1.63 | 5.34 | 19.2 | -8.13 | -15.02 | -14.18 | -10.06 | Upgrade
|
EBITDA Margin | 7.65% | -3.50% | -13.86% | 3.33% | 10.43% | 46.40% | -30.36% | -75.31% | -145.96% | -606.14% | Upgrade
|
Depreciation & Amortization | 12.34 | 3.67 | 2.4 | 2.74 | 2.66 | 1.84 | 1.77 | 1.41 | 0.61 | 0.09 | Upgrade
|
EBIT | -2.39 | -6.77 | -12.44 | -1.12 | 2.68 | 17.35 | -9.89 | -16.42 | -14.79 | -10.15 | Upgrade
|
EBIT Margin | -1.83% | -7.64% | -17.16% | -2.29% | 5.23% | 41.94% | -36.95% | -82.36% | -152.23% | -611.27% | Upgrade
|